Evidence map›Paper›PMID 37564873›Full record

ArticleFrontiers in genetics2023

NR4A1 as a potential therapeutic target in colon adenocarcinoma: a computational analysis of immune infiltration and drug response.

Mei Li, Zhongyi Zhang, Mingzhou Li, Zhe Chen, Weizhu Tang, Xiang Cheng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Mei LiDepartment of Oncology, The First Affiliated Hospital of the Hubei Three Gorges Polytechnic, Yiling Hospital of Yichang, Yichang, Hubei, China.
Zhongyi ZhangThe Second Affiliated Hospital of Guilin Medical University, Guilin Medical University, Guilin, Guangxi, China.
Mingzhou LiNanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, Guangxi, China.
Zhe ChenSchool of Information and Communication, Guilin University of Electronic Technology, Guilin, Guangxi, China.
Weizhu TangTaikang Ningbo Hospital, Ningbo, China.
Xiang ChengUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Nanxi Mountain Hospital · CNGuilin Medical University · CNGuilin University of Electronic Technology · CNWuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colon adenocarcinomaimmune infiltrationprecision medicinepredictive modelsingle cell sequencing

Identifiers

PMID37564873
PMCPMC10410285
OpenAlexW4385276993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.